Summary by Futu AI
Seth Lederman, the Chief Executive Officer of Tonix Pharmaceuticals Holding Corp. (TNXP), was reported to have engaged in a transaction involving the company's stock on February 27, 2024. The specific details of the transaction, including the number of shares, nature of the shares, transaction price, and total value of shares, were not disclosed in the announcement. As a result, the number of shares Lederman holds after the action remains unknown.